Patents by Inventor Michael Hollmann

Michael Hollmann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11919575
    Abstract: A fiber composite body, in particular a structure stiffening element, has a number of struts which are formed by reinforcing fibers which are embedded in a polymer matrix and which in a region of the respective strut run substantially parallel to one another. The struts are arranged in a truss-like profiled structure which is produced by winding or intertwining the reinforcing fibers.
    Type: Grant
    Filed: May 28, 2019
    Date of Patent: March 5, 2024
    Assignee: Bayerische Motoren Werke Aktiengesellschaft
    Inventors: Richard Gralka, Thomas Hogger, Falco Hollmann, Joachim Starke, Bernhard Staudt, Michael Voelke
  • Patent number: 5945509
    Abstract: The present invention discloses novel DNAs that encode proteins having electrophysiological and pharmacological properties characteristic of glutamate receptors. The glutamate receptors are exemplified by proteins encoded by representative cDNA clones GluR1, GluR2, GluR3, GluR4, GluR5, GluR6 and GluR7, fragments thereof, and functional combinations of these glutamate receptor proteins and/or fragments. DNA sequences from the cDNA clones for GluR1, GluR2, GluR3, GluR4 and GluR5 are especially useful as probes, thus enabling those skilled in the art to identify, without undue experimentation, other members of the L-glutamate receptor family.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: August 31, 1999
    Assignee: The Salk Institute for Biological Studies
    Inventors: Stephen F. Heinemann, James R. Boulter, Michael Hollmann, Bernhard Bettler, Jan Egebejerg Jensen
  • Patent number: 5739291
    Abstract: The present invention discloses novel DNAs that encode proteins having electrophysiological and pharmacological properties characteristic of glutamate receptors. The glutamate receptors are exemplified by proteins encoded by representative cDNA clones GluR1, GluR2, GluR3, GluR4, GluR5, GluR6 and GluR7, fragments thereof, and functional combinations of these glutamate receptor proteins and/or fragments. DNA sequences from the cDNA clones for GluR1, GluR2, GluR3, GluR5 and GluR5 are especially useful as probes, thus enabling those skilled in the art to identify, without undue experimentation, other members of the L-glutamate receptor family.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: April 14, 1998
    Assignee: The Salk Institute For Biological Studies
    Inventors: Stephen F. Heinemann, James R. Boulter, Michael Hollmann, Bernhard Bettler, Jan Egebejerg Jensen
  • Patent number: 5202257
    Abstract: The present invention discloses novel DNAs that encode proteins having electrophysiological and pharmacological properties characteristic of glutamate receptors. The glutamate receptors are exemplified by proteins encoded by representative cDNA clones GluR1, GluR2, GluR3, GluR4, GluR5, GluR6 and GluR7, fragments thereof, and functional combinations of these glutamate receptor proteins and/or fragments. DNA sequences from the cDNA clones for GluR1, GluR2, GluR3, GluR5 and GluR5 are especially useful as probes, thus enabling those skilled in the art to identify, without undue experimentation, other members of the L-glutamate receptor family.
    Type: Grant
    Filed: June 21, 1991
    Date of Patent: April 13, 1993
    Assignee: The Salk Institute for Biological Studies
    Inventors: Stephen F. Heinemann, James R. Boulter, Michael Hollmann, Bernhard Bettler, Jan E. Jensen